β-cyclodextrin nanosponges as multifunctional ingredient in water-containing semisolid formulations for skin delivery

Journal of Pharmaceutical Sciences

Volumn 103, Issue 12, 2014, Pages 3941-3949

  Conte, Claudia ^a   Caldera, Fabrizio ^b   Catanzano, Ovidio ^a   D'Angelo, Ivana ^c   Ungaro, Francesca ^a   Miro, Agnese ^a   Pellosi, Diogo Silva ^d   Trotta, Francesco ^b   Quaglia, Fabiana ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c SECOND UNIVERSITY OF NAPLES   (Italy)

^d STATE UNIVERSITY OF MARINGÁ   (Brazil)

Author keywords

Biomaterials; Complexation; Cyclodextrins; Skin; Solubility; Stability

Indexed keywords

BETA CYCLODEXTRIN; DICLOFENAC; NANOPARTICLE; RETINOIC ACID; SINGLET OXYGEN; VERTEPORFIN; BETA CYCLODEXTRIN DERIVATIVE; GEL; NANOMATERIAL; WATER;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BLEACHING; CELL VIABILITY; CREAM; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG FORMULATION; DRUG PENETRATION; DRUG SOLUBILITY; DRUG STABILITY; DRUG TRANSPORT; GEL; NONHUMAN; PHOTODYNAMICS; SKIN PERMEABILITY; SOLUBILIZATION; SPECTROFLUOROMETRY; SPECTROPHOTOMETRY; STRATUM CORNEUM; ADMINISTRATION AND DOSAGE; ANIMAL; CHEMISTRY; MEDICINAL CHEMISTRY; METABOLISM; PERMEABILITY; PIG; PROCEDURES; SKIN; SKIN ABSORPTION;

ANIMALS; BETA-CYCLODEXTRINS; CHEMISTRY, PHARMACEUTICAL; GELS; NANOSTRUCTURES; PERMEABILITY; SKIN; SKIN ABSORPTION; SWINE; WATER;

EID: 84914811625     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.24203     Document Type: Article

References (31)

1. Paudel KS, Milewski M, Swadley CL, Brogden NK, Ghosh P, Stinchcomb AL. 2010. Challenges and opportunities in dermal/transdermal delivery. Ther Deliv 1:109-131.
2. Prausnitz MR, Lias PM, Franz TJ, Schmuth M, Tsai JC, Menon GK, Holleran WM, Feingold KR. 2014. Skin barrier and transdermal drug delivery. In Dermatology; Bolognia JL, Jorizzo JL, Schaffer JV, Eds. 3rd ed.
3. Loftsson T, Masson M. 2001. Cyclodextrins in topical drug formulations: Theory and practice. Int J Pharm 225:15-30.
4. Loftsson T, Vogensen SB, Brewster ME, Konradsdottir F. 2007. Effects of cyclodextrins on drug delivery through biological membranes. J Pharm Sci 96:2532-2546.
5. Bochot A, Piel G. 2011. Applications of cyclodextrins for skin formulation and delivery. Cyclodextrins in pharmaceutics, cosmetics, and biomedicine. John Wiley & Sons, Inc., Haboken, New Jersey, USA. pp 159-176.
6. Tejashri G, Amrita B, Darshana J. 2013. Cyclodextrin based nanosponges for pharmaceutical use: A review. Acta Pharm 63:335-358.
7. Trotta F, Zanetti M, Cavalli R. 2012. Cyclodextrin-based nanosponges as drug carriers. Beilstein J Org Chem 8:2091-2099.
8. Chilajwar SV, Pednekar PP, Jadhav KR, Gupta GJ, Kadam VJ. 2014. Cyclodextrin-based nanosponges: A propitious platform for enhancing drug delivery. Expert Opin Drug Deliv 11:111-120.
9. Trotta F, Dianzani C, Caldera F, Mognetti B, Cavalli R. 2014. The application of nanosponges to cancer drug delivery. Expert Opin Drug Deliv 11:931-941.
10. Liang W, Yang C, Zhou D, Haneoka H, Nishijima M, Fukuhara G, Mori T, Castiglione F, Mele A, Caldera F, Trotta F, Inoue Y. 2013. Phase-controlled supramolecular photochirogenesis in cyclodextrin nanosponges. Chem Commun (Camb) 49:3510-3512.
11. 2CD nanosponges. J Incl Phenom Macrocycl Chem 69:403-409.
12. Rossi B, Caponi S, Castiglione F, Corezzi S, Fontana A, Giarola M, Mariotto G, Mele A, Petrillo C, Trotta F, Viliani G. 2012. Networking properties of cyclodextrin-based cross-linked polymers probed by inelastic light-scattering experiments. J Phys Chem B 116:5323-5327.
13. 2-cyclodextrin nanosponges. J Incl Phenom Macrocycl Chem 74:447-454.
14. Tashtoush BM, Jacobson EL, Jacobson MK. 2008. UVA is the major contributor to the photodegradation of tretinoin and isotretinoin: Implications for development of improved pharmaceutical formulations. Int J Pharm 352:123-128.
15. Tang W, Xu H, Kopelman R, Philbert MA. 2005. Photodynamic characterization and in vitro application of methylene blue-containing nanoparticle platforms. Photochem Photobiol 81:242-249.
16. Jacobi U, Kaiser M, Toll R, Mangelsdorf S, Audring H, Otberg N, Sterry W, Lademann J. 2007. Porcine ear skin: An in vitro model for human skin. Skin Res Technol 13:19-24.
17. Castiglione F, Crupi V, Majolino D, Mele A, Rossi B, Trotta F, Venuti V. 2012. Effect of cross-linking properties on the vibrational dynamics of cyclodextrins-based polymers: An experimental-numerical study. J Phys Chem B 116:7952-7958.
18. Ethirajan M, Chen Y, Joshi P, Pandey RK. 2011. The role of porphyrin chemistry in tumor imaging and photodynamic therapy. Chem Soc Rev 40:340-362.
19. Tessaro AL, Batistela VR, Gracetto AC, Moisés de Oliveira HP, Sernaglia RL, de Souza VR, Caetano W, Hioka N. 2011. Stability of benzoporphyrin photosensitizers in water/ethanol mixtures: pKa determination and self-aggregation processes. J Phys Org Chem 24:155-161.
20. Aveline BM, Hasan T, Redmond RW. 1995. The effects of aggregation, protein binding and cellular incorporation on the photophysical properties of benzoporphyrin derivative monoacid ring A (BPDMA). J Photochem Photobiol B 30:161-169.
21. Lovat PE, Irving H, Malcolm AJ, Pearson ADJ, Redfern CPF. 1997. 9-cis retinoic acid - A better retinoid for the modulation of differentiation, proliferation and gene expression in human neuroblastoma. J Neurooncol 31:85-91.
22. Rosso JD, Harper J, Pillai R, Moore R. 2013. Tretinoin photostability: Comparison of micronized tretinoin gel 0.05% and tretinoin gel 0.025% following exposure to fluorescent and solar light. J Clin Aesthet Dermatol 6:25-28.
23. Teraoka R, Konishi Y, Matsuda Y. 2001. Photochemical and oxidative degradation of the solid-state tretinoin tocoferil. Chem Pharm Bull (Tokyo) 49:368-372.
24. Tashtoush BM, Jacobson EL, Jacobson MK. 2008. UVA is the major contributor to the photodegradation of tretinoin and isotretinoin: Implications for development of improved pharmaceutical formulations. Int J Pharm 352:123-128.
25. Castro GA, Orefice RL, Vilela JMC, Andrade MS, Ferreira LAM. 2007. Development of a new solid lipid nanoparticle formulation containing retinoic acid for topical treatment of acne. J Microencapsul 24:395-407.
26. Kitagawa S, Kasamaki M. 2006. Enhanced delivery of retinoic acid to skin by cationic liposomes. Chem Pharm Bull 54:242-244.
27. Kogan A, Garti N. 2006. Microemulsions as transdermal drug delivery vehicles. Adv Colloid Interface Sci 123:369-385.
28. Anadolu RY, Sen T, Tarimci N, Birol A, Erdem C. 2004. Improved efficacy and tolerability of retinoic acid in acne vulgaris: A new topical formulation with cyclodextrin complex psi. J Eur Acad Dermatol Venereol 18:416-421.
29. Chen Z, Lu Y, Qi J, Wu W. 2013. Enhanced dissolution, stability and physicochemical characterization of ATRA/2-hydroxypropyl-beta-cyclodextrin inclusion complex pellets prepared by fluid-bed coating technique. Pharm Dev Technol 18:130-136.
30. Manconi M, Mura S, Sinico C, Fadda AM, Vila AO, Molina F. 2009. Development and characterization of liposomes containing glycols as carriers for diclofenac. Colloids Surf A: Physicochem Eng Asp 342:53-58.
31. Hammond SA, Tsonis C, Sellins K, Rushlow K, Scharton-Kersten T, Colditz I, Glenn GM. 2000. Transcutaneous immunization of domestic animals: Opportunities and challenges. Adv Drug Deliv Rev 43:45-55.